1Carman WF. The clinical significance of surface antigen variants of hepatitis B virus[J]. J Viral Hepat, 1997, 4 (Suppl 1):11--20
2Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus[J]. Lancet , 1990, 336 (8711):325-- 329
3Lee KM, Kim YS, Ko YY, et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child[J]. J Korean Med Sci,2001 16(3) :359--362
4Cooreman MP, van Roosmalen MH, te Morsche R, et al. Characterization of the reactivity pattern of murlne monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations [J]. Hepatology, 1999,30(5) : 1287-- 1292
5Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants[J]. J Med Virol , 1997,4 (Suppl 1) :11--20
6Seddigh-Tonekaboni S, Lim WL, Young B, et al. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient[J]. J Viral Hepat, 2001,8 (2):154 -- 158
7Weber B. Genetic variability of the S gene of hepatitis B virus Clinical and diagnostic impact[J']. J Clin Virol, 2005,32(2):102-112
3Pisarev VM, Parajuli P, Mosley RL, et al. Flt3 ligand and conjugation to IL-1beta peptide as adjuvants for a type 1,T-cell response to an HIV p17 gag vaccine[J]. Vaccine,2002,20 (17-18): 2358-2368.
4McNeel DG, Knutson KL, Schiffman K, et al. Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant [J]. J Clin Immunol,2003,23(1): 62-72.
5Hennecke M, Kwissa M, Metzger K, et al. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs [J]. Nucleic Acids Res ,2001,29(16): 3327-3334.
8Adkins JC, Wagstaff AJ. Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B. Biodrugs,1998,10(2) :137-158.
9Zuckerman JN. Non-response to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virel, 1996,50 ( 4 ) : 283- 288.
10Milich DR, Thornton GB, Neurath AR, et al. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science, 1985,228(4704) :1195-1199.
